Company Overview of Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc., an oncology therapeutics company, develops monoclonal antibody drugs targeting receptor tyrosine kinases. The company was founded in 2007 and is based in New Haven, Connecticut.
300 George Street
New Haven, CT 06511
Founded in 2007
Key Executives for Kolltan Pharmaceuticals, Inc.
Chief Executive Officer and President
Co-Founder and Chairman of the Board
Vice President of Finance and Treasurer
Compensation as of Fiscal Year 2012.
Kolltan Pharmaceuticals, Inc. Key Developments
Kolltan Pharmaceuticals Appoints Theresa M. Lavallee, Ph.D. as Vice President, Translational Medicine
Apr 2 13
Kolltan Pharmaceuticals announced the appointment of Theresa M. LaVallee, Ph.D., as Vice President, Translational Medicine, effective immediately. Dr. LaVallee will report to Jerry McMahon, Ph.D., Kolltan's President and Chief Executive Officer. Dr. LaVallee most recently served as Senior Director, Translational Medicine at MedImmune. At MedImmune, Dr. LaVallee designed and implemented translational and biomarker strategies for oncology drug development and was a key contributor to IND filings and early clinical development for many product candidates in oncology and inflammatory disease.
Kolltan Pharmaceuticals, Inc. Appoints Jane Henderson as Senior Vice President and Chief Business Officer
Feb 13 13
Kolltan Pharmaceuticals, Inc. announced the appointment of Jane Henderson as Senior Vice President and Chief Business Officer, effective immediately. Ms. Henderson will report to Gerald McMahon, Ph.D., Kolltan's President and Chief Executive Officer. Ms. Henderson has more than 24 years of experience in life sciences finance. She most recently served as Vice President, Business Development at ISTA Pharmaceuticals, Inc., where she managed the strategic option process that culminated in the successful acquisition of ISTA by Bausch + Lomb. She also oversaw the identification and evaluation of acquisitions and licensing opportunities and intellectual property strategy at ISTA. Previously, she was Executive Vice President, Chief Financial Officer and Chief Business Officer of Panacos Pharmaceuticals and served in similar roles at Axerion Therapeutics. Prior to these corporate positions, Ms. Henderson held senior investment banking positions for close to two decades in the health care groups of HSBC Securities, CIBC World Markets, Lehman Brothers and Salomon Brothers. Ms. Henderson represented clients on over 95 M&A and financing deals and attained the level of Managing Director of the Health Care Groups at HSBC and CIBC. Ms. Henderson serves as Secretary/Treasurer and Chairman of the Finance Committee on the Board of The EQUUS Foundation in Westport, CT.
Kolltan Pharmaceuticals, Inc. Presents at Boston Biotech Conference CEO New York Conference, Nov-02-2012 10:40 AM
Oct 18 12
Kolltan Pharmaceuticals, Inc. Presents at Boston Biotech Conference CEO New York Conference, Nov-02-2012 10:40 AM. Venue: Apella, 450 East 29th Street, New York, NY 10016, United States. Speakers: Jerry McMahon.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|